GLUCOKINASE GENE EXPRESSION IN THE PANCREATIC BETA CELL
胰腺β细胞中的葡萄糖激酶基因表达
基本信息
- 批准号:3243754
- 负责人:
- 金额:$ 11.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-06-01 至 1995-05-31
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting antisense nucleic acid enzyme mechanism enzyme structure fusion gene gene deletion mutation gene expression genetic promoter element glucokinase glucose metabolism molecular cloning neoplastic cell culture for noncancer research pancreatic islet function polymerase chain reaction protein purification protein structure function transcription factor transfection transposon /insertion element
项目摘要
The electrical, ionic, and secretory responses of pancreatic beta cells to
glucose are mediated by the metabolism of the sugar. Glucokinase (GK)
catalyzes the initial and rate limiting step in the utilization of glucose
by the beta cell at physiologic glucose concentrations and is thought to
play an important role in modulating insulin secretion. To study the
function and regulation of GK in the beta cell further, we have
characterized cDNAs encoding GK from both the liver and insulinoma tissue
and have mapped the mapped the transcription units in both tissues. Our
studies have shown there are two different promoters in a single GK gene.
One promoter is expressed specifically in the liver and appears to be
regulated by insulin while another promoter, located further upstream,
appears active only in the beta cell. We are proposing to study the
function and regulation of GK in insulinoma cell lines (Aim 1) and to
examine the GK beta cell promoter using a fusion gene analysis (Aim 2). In
Aim 1 complimentary approaches will be used to test the function of GK as
the beta cell "glucose sensor". By altering the expression of GK in two
different insulinoma cell lines we hope to alter the "set point" of
glucose-stimulated insulin secretion. RINm5F cells have normal glucose
uptake but appear to lack a high-Km glucose phosphorylating activity and do
not secrete insulin in response to glucose. Another cell line, beta-TC,
shows high-Km glucose usage but is stimulated to secrete insulin by less
than normal glucose concentrations. We will determine the effects of
expressing GK in the RINm5f cells and the effects of expressing GK
antisense RNA in the beta-TC cells. In Aim 2 an analysis of the beta cell
GK promoter will be undertaken using a fusion gene approach. Both a 5'
deletional analysis and the use of internal deletion mutants should enable
us to identify elements necessary for the beta cell-specific expression of
GK. Elements important for the cell type expression of GK are likely to
bind factors which are important for beta cell-specific gene expression.
These factors will be studied further using mobility shift and methylation
interference assays. Efforts to purify and clone one of these factors will
be initiated.
胰岛β细胞的电、离子和分泌反应
葡萄糖是由糖的新陈代谢调节的。葡萄糖激酶(GK)
催化葡萄糖利用的初始步骤和限速步骤
在生理葡萄糖浓度下被β细胞激活,并被认为
在调节胰岛素分泌方面起着重要作用。为了研究
GK在β细胞中的功能和调节进一步,我们有
从肝脏和胰岛素瘤组织中鉴定编码GK的cDNA
并绘制了这两个组织中的转录单位图。我们的
研究表明,在一个GK基因中有两个不同的启动子。
一个启动子在肝脏中特异表达,似乎是
受胰岛素调控,而另一个启动子位于更上游,
仅在β细胞中表现活跃。我们建议研究
GK在胰岛素瘤细胞系中的功能和调节(AIM 1)和TO
使用融合基因分析检查GKβ细胞启动子(目标2)。在……里面
目标1将使用补充方法来测试GK AS的功能
贝塔细胞的“葡萄糖传感器”。通过将GK的表达改变为两个
我们希望改变不同的胰岛素瘤细胞系的“设定点”
葡萄糖刺激的胰岛素分泌。RINm5F细胞血糖正常
摄取,但似乎缺乏高千米葡萄糖磷酸化活性和
不会因为葡萄糖而分泌胰岛素。另一种细胞系,β-TC,
显示高千米葡萄糖使用量,但刺激分泌胰岛素的量较少
而不是正常的葡萄糖浓度。我们将确定
GK在RINm5f细胞中的表达及其作用
β-TC细胞中的反义RNA。在目标2中,对β细胞的分析
GK启动子将使用融合基因方法进行。都是5英尺高的
缺失分析和内部缺失突变体的使用应该能够
美国确定贝塔细胞特异性表达所需的元件
好的。对于GK的细胞类型表达很重要的元素可能是
结合对β细胞特异性基因表达很重要的因子。
将使用迁移率变化和甲基化来进一步研究这些因素
干扰分析。提纯和克隆这些因子之一的努力将
被启动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK A MAGNUSON其他文献
MARK A MAGNUSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK A MAGNUSON', 18)}}的其他基金
Coordinating Center for Beta Cell Biology Consortium
β细胞生物学联盟协调中心
- 批准号:
8121183 - 财政年份:2010
- 资助金额:
$ 11.78万 - 项目类别:
Genetic control of pancreatic endocrine cell development
胰腺内分泌细胞发育的遗传控制
- 批准号:
7993178 - 财政年份:2010
- 资助金额:
$ 11.78万 - 项目类别:
Genetic control of pancreatic endocrine cell development
胰腺内分泌细胞发育的遗传控制
- 批准号:
8717642 - 财政年份:2010
- 资助金额:
$ 11.78万 - 项目类别:
Genetic control of pancreatic endocrine cell development
胰腺内分泌细胞发育的遗传控制
- 批准号:
8522192 - 财政年份:2010
- 资助金额:
$ 11.78万 - 项目类别:
Genetic control of pancreatic endocrine cell development
胰腺内分泌细胞发育的遗传控制
- 批准号:
8144905 - 财政年份:2010
- 资助金额:
$ 11.78万 - 项目类别:
Genetic control of pancreatic endocrine cell development
胰腺内分泌细胞发育的遗传控制
- 批准号:
8316316 - 财政年份:2010
- 资助金额:
$ 11.78万 - 项目类别:
Coordinating Center for Beta Cell Biology Consortium
β细胞生物学联盟协调中心
- 批准号:
8010566 - 财政年份:2010
- 资助金额:
$ 11.78万 - 项目类别:
Coordinating Center for Beta Cell Biology Consortium
β细胞生物学联盟协调中心
- 批准号:
7825081 - 财政年份:2009
- 资助金额:
$ 11.78万 - 项目类别:
EFFECTS OF LIVER SPECIFIC KNOCKOUT OF PEPCK ON GLUCOSE METABOLISM
肝脏特异性敲除 PEPCK 对葡萄糖代谢的影响
- 批准号:
7724113 - 财政年份:2008
- 资助金额:
$ 11.78万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 11.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 11.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 11.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 11.78万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 11.78万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 11.78万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 11.78万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 11.78万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)